Literature DB >> 9420243

Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis.

K R Jerome1, J F Tait, D M Koelle, L Corey.   

Abstract

Many viruses interfere with apoptosis of infected cells, presumably preventing cellular apoptosis as a direct response to viral infection. Since cytotoxic T lymphocytes (CTL) induce apoptosis of infected cells as part of the "lethal hit," inhibition of apoptosis could represent an effective immune evasion strategy. We report here herpes simplex virus type 1 (HSV-1) interference with CTL-induced apoptosis of infected cells and show that HSV-1 inhibits the nuclear manifestations of apoptosis but not the membrane changes. The HL-60 cell line (human promyelocytic leukemia) undergoes apoptosis in response to many stimuli, including incubation with ethanol. After HSV-1 infection (strains E115 and 17+), ethanol-treated cells did not produce oligonucleosomal DNA fragments characteristic of apoptosis, as assayed by gel electrophoresis and enzyme-linked immunosorbent assay. Inhibition was detected 2 h after infection and increased over time. Importantly, HSV-1-infected cells were resistant to apoptosis induced by antigen-specific CD4+ CTL, despite the fact that CTL recognition and degranulation in response to infected targets remained intact. Unlike HSV-1, HSV-2 (strains 333 and HG52) did not inhibit DNA fragmentation. In contrast to the inhibition of DNA fragmentation by HSV-1, none of the HSV-1 or -2 strains interfered with the ethanol-induced exposure of surface phosphatidylserine characteristic of apoptosis, as determined by annexin V binding. These results demonstrate that genes of HSV-1 inhibit the nuclear manifestations of apoptosis but not the membrane manifestations, suggesting that these may be mediated via separate pathways. They also suggest that HSV-1 inhibition of CTL-induced apoptosis may be an important mechanism of immune evasion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420243      PMCID: PMC109392     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

Review 1.  The role of T cell immunity in control of herpes simplex virus.

Authors:  D S Schmid; B T Rouse
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

Review 2.  The CTL's kiss of death.

Authors:  G Berke
Journal:  Cell       Date:  1995-04-07       Impact factor: 41.582

Review 3.  Membrane phospholipid asymmetry: host response to the externalization of phosphatidylserine.

Authors:  E M Bruckheimer; A J Schroit
Journal:  J Leukoc Biol       Date:  1996-06       Impact factor: 4.962

4.  A viral inhibitor of peptide transporters for antigen presentation.

Authors:  K Früh; K Ahn; H Djaballah; P Sempé; P M van Endert; R Tampé; P A Peterson; Y Yang
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

Review 5.  Cytotoxic T cells and human herpes virus infections.

Authors:  L K Borysiewicz; J G Sissons
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

6.  Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response.

Authors:  G A Lewandowski; D Lo; F E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

7.  Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity.

Authors:  C M Posavad; K L Rosenthal
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  Herpes simplex virus turns off the TAP to evade host immunity.

Authors:  A Hill; P Jugovic; I York; G Russ; J Bennink; J Yewdell; H Ploegh; D Johnson
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

9.  Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.

Authors:  D M Koelle; M A Tigges; R L Burke; F W Symington; S R Riddell; H Abbo; L Corey
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  HLA-DQB1 codon 57 is critical for peptide binding and recognition.

Authors:  W W Kwok; M E Domeier; M L Johnson; G T Nepom; D M Koelle
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  31 in total

1.  Adenovirus E3-6.7K maintains calcium homeostasis and prevents apoptosis and arachidonic acid release.

Authors:  Alexander R Moise; Jason R Grant; Timothy Z Vitalis; Wilfred A Jefferies
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 2.  Type I interferons and herpes simplex virus infection: a naked DNA approach as a therapeutic option?

Authors:  S Noisakran; D J Carr
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 3.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

4.  Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway.

Authors:  Daniel J J Carr; Khaldun Al-khatib; Cassandra M James; Robert Silverman
Journal:  J Neuroimmunol       Date:  2003-08       Impact factor: 3.478

Review 5.  Mapping herpes simplex virus type 1 latency-associated transcript sequences that protect from apoptosis mediated by a plasmid expressing caspase-8.

Authors:  W Peng; L Jin; G Henderson; G C Perng; D J Brick; A B Nesburn; S L Wechsler; C Jones
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

6.  Cell-type-specific tyrosine phosphorylation of the herpes simplex virus tegument protein VP11/12 encoded by gene UL46.

Authors:  George Zahariadis; Melany J Wagner; Rosalyn C Doepker; Jessica M Maciejko; Carly M Crider; Keith R Jerome; James R Smiley
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

7.  Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.

Authors:  D M Koelle; C M Posavad; G R Barnum; M L Johnson; J M Frank; L Corey
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

8.  The gene that encodes the herpes simplex virus type 1 latency-associated transcript influences the accumulation of transcripts (Bcl-x(L) and Bcl-x(S)) that encode apoptotic regulatory proteins.

Authors:  Weiping Peng; Gail Henderson; Guey-Chuen Perng; Anthony B Nesburn; Steven L Wechsler; Clinton Jones
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Herpes simplex virus type 1 (HSV-1)-induced apoptosis in human dendritic cells as a result of downregulation of cellular FLICE-inhibitory protein and reduced expression of HSV-1 antiapoptotic latency-associated transcript sequences.

Authors:  Angela Kather; Martin J Raftery; Gayathri Devi-Rao; Juliane Lippmann; Thomas Giese; Rozanne M Sandri-Goldin; Günther Schönrich
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

10.  Herpes simplex virus blocks apoptosis by precluding mitochondrial cytochrome c release independent of caspase activation in infected human epithelial cells.

Authors:  Martine Aubert; Lisa E Pomeranz; John A Blaho
Journal:  Apoptosis       Date:  2007-01       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.